Regulatory mechanisms of Na + /glucose cotransporters in renal proximal tubule cells

Abstract

Glucose is a key fuel and an important metabolic substrate in mammals. Renal proximal tubular cells (PTCs) not only reabsorb filtered glucose but are also believed to play a role in the glucotoxicity associated with renal pathogenesis, such as in diabetes. The proximal tubule environment is where 90% of the filtered glucose is reabsorbed by the low-affinity/high-capacity Na(+)/glucose cotransporter 2 (SGLT2) and facilitated diffusion glucose transporter 2 (GLUT2). Both active and facilitative glucose transporters have distinct distribution profiles along the proximal tubule related to their particular kinetic characteristics. A number of mechanisms contribute to the changes in the cellular functions, which occur in response to exposure to various endogenous factors. Hyperglycemia was reported to regulate the renal SGLT activities through the reactive oxygen species-nuclear factor-kappaB pathways, which suggests that the transcellular glucose uptake within the PTCs contribute to the development of diabetic-like nephropathy. Angiotensin II (ANG II) plays an important role in its development through epidermal growth factor receptor (EGFR) transactivation. Therefore, a combination of high glucose, ANG II, and EGF are involved in diabetic-like nephropathy by regulating the SGLT activity. In addition, endogenously enhanced SGLTs have a cytoprotective function. The renal proximal tubules play a major role in regulating the plasma glucose levels, and there is increasing interest in the renal glucose transporters on account of their potential implications in the treatment of various conditions including diabetes mellitus.

Dapagliflozin Is Effective as Add-on Therapy to Sitagliptin With or Without Metformin: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study

“…is involved in the reabsorption of the majority of glucose filtered from the glomerular filtrate back into the bloodstream (3,4).…”

The Sweet Pee Model for Sglt2 Mutation

“…SGLT1 is a high-affinity (K 0.5 ϭ 0. 4 mM) low-capacity transporter and accounts for a small amount (10%) of reabsorption of filtered glucose in normal states 1,3,4 and it does not discriminate between glucose or galactose. SGLT2 is a low-affinity (K 0.5 ϭ 2 mM) high-capacity transporter and is responsible for the majority (over 90%) of the filtered glucose reabsorbed.…”

“…SGLT2 is a low-affinity (K 0.5 ϭ 2 mM) high-capacity transporter and is responsible for the majority (over 90%) of the filtered glucose reabsorbed. 4,5 Familial renal glucosuria describes patients with a rare mutation in the solute carrier family 5, member 2 (SLC5A2) gene that encodes for a 75-kD sodium-glucose cotransporter 2 (SGLT2). Patients with this disorder manifest a variable degree of glucosuria, depending on the type of mutation and the number of alleles affected; massive glucosuria of 169 g/1.73 m 2 per d has been reported, 6 yet most of them remain euglycemic and have no other major health sequela.…”

Adverse drug reactions monitoring of newer oral hypoglycemic drugs in a tertiary care hospital of North India: a prospective study

“…As glucose is excreted, its plasma levels fall leading to an improvement in all glycemic parameters. 9,10 There is minimal potential for hypoglycemia, and no risk of overstimulation or fatigue of the beta cells. Sodium-glucose co-transporter-2 inhibitors use leads to weight reduction, about 1 to 5 kg which is more pronounced in patients with long-standing diabetes and higher baseline weight.…”